SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-292044
Filing Date
2021-10-05
Accepted
2021-10-05 16:06:04
Documents
13
Period of Report
2021-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d199223d8k.htm   iXBRL 8-K 29247
2 EX-1.1 d199223dex11.htm EX-1.1 198715
  Complete submission text file 0001193125-21-292044.txt   411556

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20211004.xsd EX-101.SCH 2883
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20211004_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20211004_pre.xml EX-101.PRE 11854
6 EXTRACTED XBRL INSTANCE DOCUMENT d199223d8k_htm.xml XML 3472
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 211306668
SIC: 2834 Pharmaceutical Preparations